Marketplace®
Every story is an economic story

Another pharma megamerger: AbbVie buys Allergan for $63 billion

Both companies are under pressure to improve their performance.

Another pharma megamerger: AbbVie buys Allergan for $63 billion
PHILIPPE HUGUEN/AFP/Getty Images

Earlier this year, Bristol-Myers Squibb announced it was buying Celgene for $74 billion. Now AbbVie, which makes popular drug Humira, has entered into an agreement to pay about $63 billion for Allergan, the manufacturer of Botox. What’s in it for both companies?

Click the audio player above to hear the full story.

Related Topics

Latest Episodes

View All Shows
  • Marketplace
    2 days ago
    25:28
  • Marketplace Morning Report
    2 days ago
    6:39
  • Marketplace Tech
    3 days ago
    13:02
  • This Is Uncomfortable
    4 days ago
    42:59
  • Million Bazillion
    13 days ago
    29:48
  • Make Me Smart
    5 months ago
    24:33